Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor Canal Block vs Oral Pain Regimen for ACL Reconstruction
NCT03365908Enrolling by invitation
- Sponsor
- University of California, Davis
- Start
- Oct 2017
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of California, Davis. Primary endpoints: Immediate Post-op Pain Score and Opioid Use. Started Oct 2017; status: enrolling by invitation.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03365908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365908.